A transnational medical services group centered on oncology, building a high-standard healthcare network that covers China and reaches Southeast Asia, Central Asia, Europe and the Americas.
Founded in 2009, Hygeia Healthcare (Stock Code: 6078.HK) is China's leading medical services group centered on oncology. Since its inception, the Group has upheld the mission of "making healthcare warmer and life healthier," dedicated to making high-quality medical resources more equitable and accessible.
Over more than a decade of development, Hygeia has established a vast medical network across multiple provinces and cities in China, operating and managing more than a dozen comprehensive hospitals centered on oncology and dozens of radiotherapy centers. We bring together top medical experts from home and abroad, providing hundreds of thousands of oncology and other patients every year with international high-standard, personalized, full-lifecycle diagnosis and treatment services.
Group Founded
Hospitals in Operation
Listed on HKEX Main Board
Building reliable medical quality through verifiable standards and long-term commitment
Using international quality standards as the foundational methodology to continuously optimize medical safety and service experience.
Endorsed by long-term capital market trust, driving sustained investment in internationalization capabilities.
Validated by multi-dimensional medical quality evaluation systems, serving as a benchmark for high-standard healthcare.
Connected with mainstream global commercial insurance systems, reducing cross-border communication and payment costs.
Flagship campuses lead standardized quality systems, while regional centers drive the implementation of advanced clinical capabilities
With flagship campuses as quality anchors, Hygeia deploys regional centers and specialty platforms in core cities, forming a more stable care delivery chain so that international patients receive a consistent service experience across cities.
Through group-level training, quality control and data-driven management, we drive a high degree of consistency in service and medical quality across campuses, ensuring every patient enjoys the same standard of premium medical resources.
An international reception hub where comprehensive oncology care, precision radiotherapy and minimally invasive surgery work in concert, with stable and traceable processes.
Focused on efficiency and multidisciplinary collaboration, introducing high-end imaging and MDT capabilities to improve decision quality for complex cases.
Serving regional patient needs with equipment platforms and standardized pathways that support stable delivery of high-frequency care.
Driving consistency in service and medical quality across campuses through group-level training, quality control and data-driven management.

Tertiary general hospital with 1,500 beds

Class III Grade A hospital with 1,200 beds

Tertiary general hospital with 1,000 beds

Class II Grade A hospital with 600 beds

Tertiary general hospital with 500 beds

Tertiary general hospital with 500 beds

Tertiary general hospital with 1,000 beds

Class II general hospital with 1,200 beds

Class II general hospital with 1,200 beds

Class III general hospital with 1,800 beds

Class II general hospital with 500 beds

Class II oncology specialty hospital with 500 beds

Class II general hospital with 200 beds

Class III general hospital with 800 beds

Class III general hospital with 600 beds

Tertiary general hospital with 800 beds

Class II general hospital with 200 beds

Class II general hospital with 1,000 beds
Turning frontier technology into deliverable, reusable and continuously iterable clinical capabilities
Millimeter-level positioning and precise targeting strategies that balance efficacy with protection of surrounding tissues, enhancing treatment certainty.
Clearer vision and more refined operating paths that reduce trauma and shorten recovery, improving the post-operative experience.
Breaking complex problems into actionable plans, reducing uncertainty through expert collaboration to improve decision quality.
Combining genomic sequencing with individual differences to formulate more precise systemic treatment strategies for more controllable care.
Every step is clearly traceable, and every expansion puts medical quality first
Leave the complexity to us, and focus on your treatment
Please fill in the following information. Our international medical team will contact you within 24 hours. Your privacy is strictly protected.